2 completed, 1 recruiting, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
Follow Damien Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Triple-dose Tuberculosis Retreatment Regimen 6EH³R³Z, 6EHRZ - Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Recruiting | Institute of Tropical Medicine, Belgium | 370 | 2021-03-01 | 2025-04-13 |
| Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More 6EH³RZ, 6EHR³Z, 6EHRZLfx - Tuberculosis, Pulmonary | Phase 3 | Withdrawn | Institute of Tropical Medicine, Belgium | 2019-09-30 | 2020-01-21 | |
| Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar Rifampicin - Leprosy | Phase 3 | Completed | Institute of Tropical Medicine, Belgium | 144000 | 2019-01-02 | 2025-03-04 |
| Optimization of the TB Treatment Regimen Cascade double rimfampicin, Standard TB treatment - Tuberculosis, Pulmonary | Phase 3 | Completed | Damien Foundation | 701 | 2014-11-01 | 2020-02-13 |
Tuberculosis, Pulmonary (3) · Leprosy (1) · Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1)
Rifampin (2) · Ethambutol (1) · Isoniazid (1) · Pyrazinamide (1)
Bangladesh (2) · Comoros (1) · Madagascar (1) · Niger (1)
Aung Kya Jai Maug, MD (1) · Bertrand Cauchoix, MD (1) · Bouke de Jong, MD, PhD (1) · Epco Hasker, MD (1) · Sani Kadri (1) · Tom Decroo, MD (1) · Younoussa Assoumani, MD (1)